Photo by nci from unsplash
3076Background: In advanced cancer, the overall response rate (ORR) following anti-PD1 monotherapy is variable (0% to 50%). Here, we hypothesized that this observation is partly explained by differ... Click to show full abstract
3076Background: In advanced cancer, the overall response rate (ORR) following anti-PD1 monotherapy is variable (0% to 50%). Here, we hypothesized that this observation is partly explained by differ...
Keywords:
pd1 monotherapy;
anti pd1;
response;
association pd1;
pd1 mrna
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!